We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Tacks on 3 More Chinese Drugmakers to Import Alert Lists
FDA Tacks on 3 More Chinese Drugmakers to Import Alert Lists
The FDA is continuing its crackdown on Chinese drugmakers, adding three more companies this week to its import alert lists over faulty GMP practices and a refusal for inspection.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor